Clinical study on total hip replacement in patients with osteonecrosis of the femoral head combined with HIV infection
Objective To explore the safety of total hip arthroplasty in patients with osteonecrosis of the femoral head(ONFH)combined with human immunodeficiency virus(HIV)infection.Methods A total of 55 ONFH patients who underwent total hip replacement in the Orthopedics Department of the hospital from January 2021 to December 2022 were selected,including 24 HIV-infected patients(the HIV-ONFH group)and 31 non-HIV-infected patients(the NHIV-ONFH group).The levels of hematocrit(Hct),total blood loss(TBL),dominant blood loss(DBL),hidden blood loss(HBL),transfusion rate,surgical time,Harris score of hip joint function,and incidence of complications between the two groups were compared.Results There were no statistically significant differences in the levels of HB,Hct,and HB decrease value be-fore and after surgery between the two groups(P＞0.05).There were no statistically significant differences in terms of TBL,transfusion rate,and Harris score at one week after surgery between the two groups(P＞0.05).There were statistically significant differences in DBL,HBL,and surgical time between the two groups(P＜0.05).No related complications occurred during hospitalization in the two groups,and postoperative pain relief and functional recovery were good.Conclusion Total hip replacement for ONFH patients with HIV in-fection is safe and effective,and will not increase the risk of bleeding.
Total hip replacementHuman immunodeficiency virusOsteonecrosis of the femoral head
万方数据
维普
